The Powell Perspective

As AI chips grow, a physical flaw threatens to halt progress. A US-made material offers a breakthrough, promising silicon-matched performance without costly retooling.

XBOW's new AWS Security Competency isn't just a badge. It marks a critical shift to autonomous, AI-driven defense against AI-accelerated threats.

The FDA has fast-tracked mitapivat for sickle cell disease, offering new hope for patients. But a closer look reveals the high stakes of this strategy.

VR Resources' deep drill at New Boston validates advanced geophysics, revealing a vast polymetallic system vital for North American resource independence.

IceCure's ProSense™ is reshaping oncology in Brazil. A US FDA approval provided a critical tailwind, validating a less invasive future for cancer care.

As cyber threats target our most vulnerable, one of the nation's largest hospice providers is making a critical investment in digital defense. Is it enough?

As marketing leaders face shrinking budgets and C-suite skepticism, a new 'showrunner' model from creative studio della promises to fix brand drift. But is it a revolution or just clever rebranding?

The new BNPL partnership promises convenience, but a closer look reveals a complex calculus of consumer risk, retail survival, and regulatory scrutiny.

Hyundai's record first-half sales, powered by a massive hybrid surge, reveal a winning strategy. But a deep dive shows a fractured EV market.

Galderma's innovative neuromodulator, a key to its 'powerhouse' ambitions, hits a U.S. roadblock. The FDA's concerns? Manufacturing, not safety.

A North Dakota town is marketed as a haven from urban chaos. But what does the data show? We dissect Dickinson's appeal, its complex market, and the new media shaping its story.

TowneBank adds agribusiness and M&A powerhouses to its board, signaling a dual strategy of deep community integration and aggressive regional expansion.

California Credit Union’s school supply drive is more than charity; it’s a look into a new model of corporate responsibility tackling educational inequity.

A high-stakes hire at 360 Privacy signals a critical shift in security, as personal data exposure becomes the primary vector for physical and reputational attacks.

ManageEngine launches its developer Marketplace, entering a field dominated by giants. Can its 'symbiotic' model and strict security governance set it apart?

Kowa's pemafibrate gets FDA Breakthrough status for a rare liver disease. We dissect what this means for patients, the science, and the company's global strategy.

An AI education firm and its investors allege a massive market manipulation scheme by Citadel and Virtu, turning a class action into a test case for fair markets.

Webull Canada's new CIRO-approved crypto trading offers mainstream access, but a closer look reveals the unmitigated risks lurking beneath the regulatory sheen.

A new book by a political theorist argues we're asking the wrong questions about AI. The real danger isn't a rogue mind, but our own institutional trust.

As new treatments for degenerative eye disease emerge, OpZira's hiring of a key innovator from its past signals a major push into AI-driven diagnostics.